• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: PENUMBRA, INC. PENUMBRA SYSTEM 5MAX SEPARATOR; NRY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

PENUMBRA, INC. PENUMBRA SYSTEM 5MAX SEPARATOR; NRY Back to Search Results
Catalog Number PSF054
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Hemorrhage, Subarachnoid (1893); Perforation of Vessels (2135)
Date of Event 05/13/2013
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
The product was not returned for evaluation.From the information provided, there is no indication that there was any device malfunction, nonconformance, or misuse that contributed to the reported event.Perforation and hemorrhage, are known and anticipated complications with these types of procedures and are noted in the device labeling.Therefore, it was determined that these reported adverse events were anticipated procedural complications.The manufacturing records for this lot were reviewed and did not reveal any outstanding discrepancies, design, or quality concerns.This report is associated with mfr report numbers: 3005168196-2016-00556, 3005168196-2016-00558, 3005168196-2016-00559.The hospital disposed of the device.
 
Event or Problem Description
The patient underwent a thrombectomy procedure in the middle cerebral artery (mca) using a penumbra system 5max reperfusion catheter, a penumbra system 5max separator, a penumbra system 3max reperfusion catheter and a penumbra system 3max separator.During the procedure, there was suspicion of tiny vessel perforation in left m3 segment - distant from the site of device placement; however, angiogram was unable to clearly confirm this.The final runs showed that the vessel was recanalized and also showed a vasospasm.At 14:25 hours, a follow up computerized tomography (ct) was performed and showed a circumscribed subarachnoid hemorrhage (sah) at the left insula.On postoperative day 1, another ct was performed and revealed that the sah had nearly completely resolved and only tiny spots of sah was seen in left dorsal insula.On (b)(6) 2013, the patient was discharged to a rehabilitation center.On (b)(6) 2013, the patient was seen again for a follow up visit and examination showed neurological and functional improvement.The reported vasospasm was reviewed and adjudicated by the committee to be a non-serious adverse event that was definitely related to the angiographic procedure, and unrelated to the penumbra system and the index stroke.The reported small sah was reviewed and adjudicated by the committee to be a non-serious adverse event that was related to the angiographic procedure and the penumbra system.The hemorrhage was noted to be due to perforation above the m3 branch.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PENUMBRA SYSTEM 5MAX SEPARATOR
Common Device Name
NRY
Manufacturer (Section D)
PENUMBRA, INC.
one penumbra place
alameda CA 94502
MDR Report Key5619661
Report Number3005168196-2016-00557
Device Sequence Number10825623
Product Code NRY
UDI-Device Identifier00814548010434
UDI-Public00814548010434
Combination Product (Y/N)N
Initial Reporter StateIA
Initial Reporter CountryUS
PMA/510(K) Number
K133317
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source company representative,health
Initial Reporter Occupation Other
Type of Report Initial
Report Date (Section B) 03/30/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Physician
Device Expiration Date08/31/2015
Device Catalogue NumberPSF054
Device Lot NumberF29443
Was Device Available for Evaluation? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 03/30/2016
Initial Report FDA Received Date04/29/2016
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Life Threatening; Other;
Patient Age64 YR
-
-